Clinical trial
The 10-Year Extended Follow-up of the Different Antiplatelet Strategies After Coronary Artery Bypass Grafting Trial
NCT07480629 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The 10-Year Extended Follow-up of the Different Antiplatelet Strategies After Coronary Artery Bypass Grafting Trial
- Lead sponsor
- Ruijin Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 15, 2026
- Completion date
- July 30, 2026
- Enrollment
- 500 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antiplatelet therapy of coronary artery bypass, cabg, coronary artery disease